From 1 July 2023, Vaxelis® will be added to the National Immunisation Program (NIP). Vaxelis® is a hexavalent (six-in-one) vaccine that protects against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and haemophilus influenzae type B (Hib). Vaxelis® is registered for use from 6 weeks of age. It does not require reconstitution.
More information will be shared when it becomes available. Register for our CPD education event Childhood Vaccination Schedule update which will provide in depth information about Vaxelis® and the updates to the childhood National Immunisation Program (NIP) schedule.
Protect your patients from flu and COVID by ensuring they are vaccinated
NSW Health is urging people aged 65 and over to book in for their free influenza (flu) vaccine through their GP or local pharmacy, amid concerns of moderate levels of influenza transmission in the community.
More than 9,000 people in NSW were diagnosed with influenza during the past fortnight, 4 June to 17 June, with the latest data showing an increase in the number of people who presented to NSW emergency departments in June with influenza-like illness.
Influenza vaccination coverage in the central and eastern Sydney PHN region is behind that of NSW in the over 65 population, with only 48 per cent of people vaccinated, compared to the NSW coverage rate of 57 per cent. Additionally, only 25 per cent of children aged less than 5 years within CESPHN region are currently vaccinated against flu.
Those considered to be at higher risk of severe illness from influenza are eligible for a free flu vaccine and include:
People aged 65 and over
Children aged six months to under five years
Aboriginal people from six months of age
Those with serious health conditions such as diabetes, cancer, immune disorders, obesity, severe asthma, kidney, heart, lung or liver disease.
Contact us at email@example.com if you require assitance in generating a list of your patients overdue for flu or COVID vaccinations for follow up.
Discontinuation of Pfizer 12 years+ (Purple)
Expiry: All Pfizer 12 years+(purple) vaccine doses will expire on 30 June 2023. Providers should dispose vaccines on 1 July (the day after expiry) and report any wastage in CVAS.
Offboarding: Pfizer 12 years+(purple) stock is discontinued and can no longer be ordered. Once stock on hand in CVAS shows zero and all reporting has been completed, this vaccine product will be automatically deactivated in CVAS.
Workshop: Addressing vaccine hesitancy
About: interactive workshop taking a scenario-based approach to address low vaccine confidence and provide strategies to identify and engage patients who are hesitant to vaccination.
About: recent updates to the childhood National Immunisation Program (NIP) schedule, specifically regarding the addition of Vaxelis, and key differences between the hexavalent vaccines available on the NIP. We will also provide an overview of infectious diseases common in children and discuss declining childhood immunisation coverage rates in the CESPHN region. This event will also be live streamed so you can join online.
When: Thursday | 3 August 2023 | 6:30pm – 8:30pm
Registration (hybrid event):
Register for IN PERSON attendance at The Waterfront Function Centre @ St George Motor Boat Club, 2 Wellington Street, Sans Souci, NSW 2219
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Launch of new Australian Guideline for assessing and managing cardiovascular disease risk The 2023 Australian Guideline for assessing and managing cardiovascular disease risk, and associated Australian cardiovascular disease risk calculator (Aus CVD Risk Calculator), will become the new standard of care for the primary prevention of CVD in Australia. This…
At CESPHN we value your feedback and invite you to complete the 2023 stakeholder engagement survey At CESPHN, we value your feedback and invite you to complete the stakeholder engagement survey on our service delivery and communication over the past 12 months. This short survey only takes five minutes and…
CESPHN Healthy Ageing Strategy 2023-28 has been released The Central and Eastern Sydney PHN has developed a Healthy Ageing Strategy to empower older people in our region to live more active and fulfilling lives, enabled by inclusive communities, and supported by integrated person-centred health and social services. Healthy ageing relies…
NSW community urged to be on alert amid rise in listeriosis NSW Health is reminding people who are immunocompromised, pregnant, or aged over 65 years to avoid foods that can cause listeriosis, following several confirmed cases of listeria infection in NSW. Listeriosis infection, which comes from consuming food contaminated with…
CESPHN Primary Health Awards: 2023 Finalists and Winners announced At a packed event last night at the Hazelhurst Arts Centre in Gymea, CESPHN held its annual Primary Health Awards. CESPHN’s multicultural community was reflected in our numerous and diverse submissions. All immensely impressive. The winners, announced at the awards event,…